Miri Wernli

Miri Wernli

President at MIND MEDICINE (MINDMED) INC.

Net worth: 775 847 $ as of 29/04/2024

71 year
44 connections
Consumer Services
Health Technology

Miri Wernli active positions

CompaniesPositionStartEnd
MIND MEDICINE (MINDMED) INC. President 31/01/2021 -
Director/Board Member 27/02/2020 10/08/2022
Corporate Officer/Principal 12/08/2020 31/01/2021

Career history of Miri Wernli

Former positions of Miri Wernli

CompaniesPositionStartEnd
Actelion Pharmaceuticals US, Inc.
Logo Actelion Pharmaceuticals US, Inc.

Actelion Pharmaceuticals US, Inc.

Pharmaceuticals: MajorHealth Technology

Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera.

 Corporate Officer/Principal 31/12/2006 31/12/2015
MELODIOL GLOBAL HEALTH LIMITED Director/Board Member - -
Chief Executive Officer - 14/08/2020
Chief Tech/Sci/R&D Officer 14/08/2020 -
Founder 19/11/2015 -

Training of Miri Wernli

Stanford University Masters Business Admin
University of Geneva Doctorate Degree

Statistics

International

United States 3
Switzerland 2
Australia 2

Operational

Director/Board Member 2
Corporate Officer/Principal 2
Chief Executive Officer 1

Sectoral

Consumer Services 3
Health Technology 3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies1
MELODIOL GLOBAL HEALTH LIMITED

Health Technology

Private companies2
Actelion Pharmaceuticals US, Inc.
Logo Actelion Pharmaceuticals US, Inc.

Actelion Pharmaceuticals US, Inc.

Pharmaceuticals: MajorHealth Technology

Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera.

Health Technology

Mind Medicine (MindMed), Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Miri Wernli
  4. Experience